|
Shertzer, H G; Puga, A; Chang, C et al. (1999) Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones. Chem Biol Interact 123:31-49
|
|
Maier, A; Micka, J; Miller, K et al. (1998) Aromatic hydrocarbon receptor polymorphism: development of new methods to correlate genotype with phenotype. Environ Health Perspect 106:421-6
|
|
Fitzgerald, C T; Nebert, D W; Puga, A (1998) Regulation of mouse Ah receptor (Ahr) gene basal expression by members of the Sp family of transcription factors. DNA Cell Biol 17:811-22
|
|
DiRocco, L; Dalton, T; Liang, D et al. (1998) Nonallelism for the audiogenic seizure prone (Asp1) and the aryl hydrocarbon receptor (Ahr) loci in mice. J Neurogenet 12:191-203
|
|
Micka, J; Milatovich, A; Menon, A et al. (1997) Human Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. Pharmacogenetics 7:95-101
|
|
He, X X; Nebert, D W; Vasiliou, V et al. (1997) Genetic differences in alcohol drinking preference between inbred strains of mice. Pharmacogenetics 7:223-33
|
|
Nebert, D W (1997) Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 60:265-71
|
|
Nebert, D W; Duffy, J J (1997) How knockout mouse lines will be used to study the role of drug-metabolizing enzymes and their receptors during reproduction and development, and in environmental toxicity, cancer, and oxidative stress. Biochem Pharmacol 53:249-54
|
|
Nebert, D W; Carvan 3rd, M J (1997) Ecogenetics: from ecology to health. Toxicol Ind Health 13:163-92
|
|
Nebert, D W; McKinnon, R A; Puga, A (1996) Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 15:273-80
|
Showing the most recent 10 out of 14 publications
